Skip to main content

Implementing tight glycaemic control: performance of bedside glucometers


Implementing tight glycaemic control (TGC) in the ICU requires accurate blood glucose (BG) monitoring. We evaluated the performance of two bedside glucometers (GM) in ICU patients.


Four hundred and fifty-two arterial blood samples were prospectively analysed in 37 adult ICU patients subjected to TGC. Arterial BG was simultaneously determined using a reference test (ABL®) and two GM (Accu-Chek® and HemoCue®). Data were analysed using linear regression and the Bland–Altman (BA) method.


Correlation between the reference method and both GM in the overall BG range was reasonable, but not perfect (r2 ≥ 0.93). This was further underlined by BA analysis (Figures 1 and 2), showing a bias to overestimate BG with GM. In the TGC range (80–110 mg/dl) correlation was low for both GM (r2 ≤ 0.66). This was confirmed by BA analysis, demonstrating broad limits of agreement: +14.2 and -26.6 mg/dl for Accu-Chek® and +5.5 and -31.1 mg/dl for HemoCue®.

Figure 1
figure 1

(abstract P141)

Figure 2
figure 2

(abstract P141)


The accuracy of the tested GM in our ICU patients was insufficient for safe clinical practice. Therefore, to avoid potentially harmful hypoglycaemia, caution is warranted when TGC is implemented exclusively based on BG results obtained by GM.

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Vlasselaers, D., Vandewiele, K., Herpe, T.V. et al. Implementing tight glycaemic control: performance of bedside glucometers. Crit Care 11 (Suppl 2), P141 (2007).

Download citation

  • Published:

  • DOI: